相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis
Kazuto Tajiri et al.
DIGESTIVE DISEASES (2018)
Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema
Masanori Atsukawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
JOURNAL OF HEPATOLOGY (2018)
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Paolo Caraceni et al.
LANCET (2018)
Balanced Crystalloids versus Saline in Critically Ill Adults
Matthew W. Semler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema
Yasunari Hiramine et al.
HEPATOLOGY RESEARCH (2017)
Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study
Haruki Uojima et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Utility and Safety of Tolvaptan in Cirrhotic Patients with Hyponatremia: a Prospective Cohort Study
Ji-Dong Jia et al.
ANNALS OF HEPATOLOGY (2017)
Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience
Elisa Pose et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Safety and efficacy of long-term tolvaptan therapy for decompensated liver cirrhosis
Tomomi Kogiso et al.
HEPATOLOGY RESEARCH (2016)
Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver Cirrhosis
Hirokazu Chishina et al.
DIGESTIVE DISEASES (2016)
Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation
Peijie Wang et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials
Long Yan et al.
BMC GASTROENTEROLOGY (2015)
Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial
Thierry Thevenot et al.
JOURNAL OF HEPATOLOGY (2015)
Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis
Vishwadeep Ahluwalia et al.
JOURNAL OF HEPATOLOGY (2015)
Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis
Mauro Bernardi et al.
JOURNAL OF HEPATOLOGY (2015)
Disorders of Plasma Sodium - Causes, Consequences, and Correction
Richard H. Sterns
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Clinical practice guideline on diagnosis and treatment of hyponatraemia
Goce Spasovski et al.
INTENSIVE CARE MEDICINE (2014)
Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
Rajiv Jalan et al.
JOURNAL OF HEPATOLOGY (2014)
A UNIFIED THEORY OF SEPSIS- INDUCED ACUTE KIDNEY INJURY: INFLAMMATION, MICROCIRCULATORY DYSFUNCTION, BIOENERGETICS, AND THE TUBULAR CELL ADAPTATION TO INJURY
Hernando Gomez et al.
SHOCK (2014)
Early mortality and long-term survival after abdominal surgery in patients with liver cirrhosis
Hannes P. Neeff et al.
SURGERY (2014)
Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure
E. Prakoso et al.
INTERNAL MEDICINE JOURNAL (2013)
Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity
Florence Wong et al.
GUT (2012)
Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials
Mauro Bernardi et al.
HEPATOLOGY (2012)
Association Between a Chloride-Liberal vs Chloride-Restrictive Intravenous Fluid Administration Strategy and Kidney Injury in Critically Ill Adults
Nor'azim Mohd Yunos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis
Andres Cardenas et al.
JOURNAL OF HEPATOLOGY (2012)
Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites
Thomas Serste et al.
JOURNAL OF HEPATOLOGY (2012)
Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study
Monica Guevara et al.
JOURNAL OF HEPATOLOGY (2012)
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Perioperative Mortality After Non-hepatic General Surgery in Patients with Liver Cirrhosis: an Analysis of 138 Operations in the 2000s Using Child and MELD Scores
Hannes Neeff et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds
Pantelis A. Sarafidis et al.
EXPERT OPINION ON DRUG SAFETY (2010)
TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update
Martin Roessle et al.
GUT (2010)
Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis
Florence Wong et al.
JOURNAL OF HEPATOLOGY (2010)
Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival
Raghavan Murugan et al.
KIDNEY INTERNATIONAL (2010)
Organic osmolytes in hyponatremia and ammonia toxicity
Jessica Heins et al.
METABOLIC BRAIN DISEASE (2010)
Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence
Juan Cordoba et al.
METABOLIC BRAIN DISEASE (2010)
Hyponatremia Is a Risk Factor of Hepatic Encephalopathy in Patients With Cirrhosis: A Prospective Study With Time-Dependent Analysis
Monica Guevara et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Impact of Pretransplant Hyponatremia on Outcome Following Liver Transplantation
Byung Cheol Yun et al.
HEPATOLOGY (2009)
Conivaptan Increases Serum Sodium in Hyponatremic Patients with End-Stage Liver Disease
Jacqueline G. O'Leary et al.
LIVER TRANSPLANTATION (2009)
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome:: A randomized study
Marta Martin-Llahi et al.
GASTROENTEROLOGY (2008)
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome
Arun J. Sanyal et al.
GASTROENTEROLOGY (2008)
Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia:: A randomized trial
Pere Gines et al.
HEPATOLOGY (2008)
Hyponatremia in cirrhosis:: Pathogenesis, clinical significance, and management
Pere Gines et al.
HEPATOLOGY (2008)
Hyponatremia and mortality among patients on the liver-transplant waiting list
W. Ray Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hepatic encephalopathy
Juan Cordoba et al.
SEMINARS IN LIVER DISEASE (2008)
Transjugular intrahepatic portosystemic shunt for refractory ascites:: A meta-analysis of individual patient data
Francesco Salerno et al.
GASTROENTEROLOGY (2007)
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation
Maria-Carlota Londono et al.
GUT (2007)
Hyponatremia in cirrhosis:: Results of a patient population survey
Paolo Angeli et al.
HEPATOLOGY (2006)
Evidence-based incorporation of serum sodium concentration into MELD
Scott W. Biggins et al.
GASTROENTEROLOGY (2006)
Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation
MC Londoño et al.
GASTROENTEROLOGY (2006)
In vivo imaging of cerebral peripheral benzodiazepine binding sites'' in patients with hepatic encephalopathy
A Cagnin et al.
GUT (2006)
Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit
M Holtkamp et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis
T Restuccia et al.
HEPATOLOGY (2004)
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: A randomized double-blind multicenter trial
AL Gerbes et al.
GASTROENTEROLOGY (2003)
Disorders of body water homeostasis
JG Verbalis
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients
P Amodio et al.
JOURNAL OF HEPATOLOGY (2001)
A model to predict survival in patients with end-stage liver disease
PS Kamath et al.
HEPATOLOGY (2001)
Primary care:: Hyponatremia.
HJ Adrogué et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Primary care -: Hypernatremia
HJ Adrogué et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The astrocytic (peripheral-type) benzodiazepine receptor: role in the pathogenesis of portal-systemic encephalopathy
RF Butterworth
NEUROCHEMISTRY INTERNATIONAL (2000)
分享论文
